| Quarterly Financials | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
Revenue  | 0 | 1 | 1 | 3 | 3 | 1 | 2 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 3 | 3 | 1 | 3 | 4 | 3 | 1 | 3 | 2 | 6 | 2 | 2 | 6 | 8 | 9 | 8 | 7 | 4 | 2 | 3 | 2 | 1 | 9 | 55 | 45 | 6 | 10 |
| Expenses | 0 | 1 | 1 | 2 | 3 | 1 | 2 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 3 | 3 | 1 | 2 | 4 | 3 | 0 | 3 | 2 | 6 | 2 | 1 | 5 | 8 | 9 | 7 | 6 | 5 | 2 | 3 | 1 | 1 | 9 | 55 | 45 | 7 | 9 |
| EBITDA | -0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | -0 | -0 | -0 | 0 | -0 | 1 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | -0 | 0 | 0 | 0 | -1 | 0 | 1 | 0 | -0 | 0 |
| Operating Profit % | 0 % | -19 % | -42 % | 5 % | 5 % | 19 % | 9 % | 12 % | 18 % | -14 % | -200 % | -3 % | -17 % | -1,900 % | -3 % | -2 % | -23 % | 5 % | 6 % | -2 % | -17 % | 1 % | 2 % | -7 % | 6 % | -2 % | 10 % | 0 % | 6 % | 4 % | 4 % | -3 % | 15 % | 4 % | 8 % | -200 % | 2 % | 1 % | 0 % | -4 % | -1 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 | 0 | -0 | 0 | 0 | -0 | -0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | -0 | 0 | 0 | 0 | -1 | 0 | 1 | 0 | -0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 | 0 | -0 | 0 | 0 | -0 | -0 | 0 | 0 | 1 | -0 | 1 | 0 | 0 | -0 | 0 | 0 | 0 | -1 | 0 | 1 | 0 | -0 | 0 |
| EPS in ₹ | -0.56 | -0.38 | -0.78 | 0.32 | 0.15 | 0.05 | 0.20 | 0.11 | 0.25 | -0.31 | -0.66 | -0.38 | -0.54 | -0.76 | -0.41 | -0.19 | -0.42 | 0.52 | 0.41 | -0.32 | 0.80 | 0.65 | -0.12 | -0.50 | 0.19 | 0.42 | 1.15 | -0.26 | 0.12 | 0.07 | 0.05 | -0.10 | 0.07 | 0.00 | 0.01 | -0.25 | 0.02 | 0.14 | 0.05 | -0.11 | 0.04 |
Vivanza Biosciences
Vivanza Biosciences
1.80
+0.05
(2.86%)
Market Cap
7.20 Cr
PE Ratio
15.91
Volume
11,010.00
Day High - Low
1.80 - 1.74
52W High-Low
2.72 - 1.52
Key Fundamentals
Market Cap
7.20 Cr
EPS
0.10
PE Ratio
15.91
PB Ratio
1.61
Book Value
1.09
EBITDA
0.80
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
9.05
Debt to Equity
2.26
Actual
Company News
View All News
Vivanza Biosciences Ltd held a board meeting on August 17, 2026, approving the 44th AGM, new MoA/AoA, and related party transactions for FY27. Shareholder approval sought for borrowing limits.
Vivanza Biosciences Q1FY27 Results
Aug 08, 2026
Aug 08, 2026Vivanza Biosciences Limited files unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, under SEBI regulations.
Vivanza Biosciences Q1FY26 ResultsAug 07, 2026
Aug 07, 2026Vivanza Biosciences reports Q1FY26 net profit of ₹14.51 lakh, a sharp turnaround from the loss in the previous quarter. Revenue rises 17% YoY to ₹914.09 lakh.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,910.00 | #1 4,58,272.98 | 37.64 | #1 61,673.90 | 12.69 | #1 11,565 | 26.53 | 45.69 | |
8,496.00 | 2,25,542.11 | 77.60 | 11,067.00 | 13.95 | 2,568 | 65.50 | 67.19 | |
4,886.50 | 1,85,866.75 | 86.11 | 13,886.20 | 20.34 | 2,138 | 3.28 | 48.05 | |
1,437.90 | 1,16,160.08 | 34.33 | 29,044.60 | 2.24 | 3,870 | -39.18 | 48.21 | |
1,103.80 | 1,11,068.11 | 24.33 | 27,657.90 | 17.64 | 5,026 | -34.90 | 44.37 | |
2,188.00 | 1,00,042.48 | #1 18.06 | 29,038.90 | #1 26.75 | 5,356 | 16.00 | 27.99 | |
1,190.00 | 99,325.62 | 30.81 | 35,058.60 | 3.90 | 4,158 | -69.10 | 48.40 | |
2,374.50 | 98,065.89 | 47.38 | 14,636.40 | 14.85 | 1,938 | 29.13 | 38.57 | |
1,801.00 | 97,228.17 | 89.92 | 6,867.80 | 22.01 | 890 | #1 123.93 | 59.80 | |
1,608.00 | 92,520.77 | 25.36 | 34,145.20 | 5.56 | 3,503 | 25.21 | 51.29 |
Growth Rate
Revenue Growth
1,446.67 %
Net Income Growth
-157.14 %
Cash Flow Change
-3.20 %
ROE
-153.20 %
ROCE
-464.73 %
EBITDA Margin (Avg.)
-118.20 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 1 | 7 | 10 | 11 | 12 | 8 | 16 | 23 | 20 | 17 | 22 |
| Fixed Assets | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Current Assets | 0 | 4 | 7 | 8 | 9 | 5 | 13 | 20 | 16 | 12 | 19 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 1 | 5 | 8 | 9 | 10 | 6 | 13 | 20 | 17 | 14 | 20 |
| Total Equity & Liabilities | 1 | 7 | 10 | 11 | 12 | 8 | 16 | 23 | 20 | 17 | 22 |
| Current Liabilities | 1 | 3 | 6 | 7 | 9 | 5 | 10 | 17 | 12 | 9 | 17 |
| Non Current Liabilities | 0 | 0 | 1 | 1 | 0 | 0 | 3 | 1 | 3 | 3 | 1 |
| Total Equity | 0 | 4 | 4 | 3 | 3 | 3 | 4 | 4 | 5 | 4 | 4 |
| Reserve & Surplus | -0 | -1 | -0 | -1 | -1 | -1 | -1 | 0 | 1 | 0 | 0 |
| Share Capital | 0 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
Cash Flow
| Cash Flow | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Net Cash Flow | 0 | 0 | -1 | 0 | 0 | -0 | 0 | 0 | 0 | -0 | -0 |
| Investing Activities | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 |
| Operating Activities | 0 | -2 | -0 | 1 | 3 | -3 | 3 | -1 | 2 | -3 | -3 |
| Financing Activities | 0 | 0 | -1 | -1 | -3 | 3 | -3 | 1 | -2 | 3 | 3 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 47.80 % | 47.80 % | 47.80 % | 47.80 % | 47.80 % | 47.80 % | 47.80 % | 47.80 % | 47.80 % | 47.80 % | 47.29 % | 44.90 % | 43.24 % | 40.05 % | 39.86 % | 20.02 % | 20.02 % | 20.02 % | 20.02 % | 20.02 % | 20.02 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 4.57 % | 4.54 % | 4.89 % | 6.53 % | 5.67 % | 5.67 % | 5.67 % | 5.67 % | 5.65 % | 5.66 % | 6.23 % | 9.06 % | 13.82 % | 45.01 % | 51.05 % | 71.21 % | 73.69 % | 73.36 % | 73.34 % | 73.42 % | 73.34 % |
| Others | 47.63 % | 47.65 % | 47.31 % | 45.66 % | 46.53 % | 46.53 % | 46.53 % | 46.53 % | 46.55 % | 46.54 % | 46.48 % | 46.04 % | 42.94 % | 14.94 % | 9.09 % | 8.77 % | 6.29 % | 6.62 % | 6.64 % | 6.56 % | 6.64 % |
| No of Share Holders | 0 | 4,617 | 4,613 | 4,619 | 4,641 | 4,643 | 4,636 | 4,662 | 4,865 | 4,867 | 5,039 | 5,937 | 6,992 | 16,941 | 16,701 | 20,635 | 20,833 | 20,458 | 20,170 | 19,822 | 19,461 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 11 Sept 2026 |  Annual General Meeting | NA | 11 Sept 2026 | 1.77 | 1.75 |
| 21 Jul 2022 | Annual General Meeting | NA | 21 Jul 2022 | 18.90 | 19.50 |
| 24 Jan 2023 |  Split | 1:10 | 24 Mar 2023 | 14.73 | 14.73 |
| 01 Aug 2024 | Annual General Meeting | NA | 01 Aug 2024 | 5.01 | 4.80 |
| 17 Oct 2024 |  Quarterly Result Announcement | NA | 17 Oct 2024 | 4.07 | 3.81 |
| 31 Jan 2025 | Quarterly Result Announcement | NA | 31 Jan 2025 | 3.07 | 2.98 |
| 12 May 2025 | Quarterly Result Announcement | NA | 12 May 2025 | 2.18 | 2.08 |
| 13 Aug 2025 | Quarterly Result Announcement | NA | 13 Aug 2025 | 2.04 | 2.09 |
| 25 Sept 2025 | Annual General Meeting | NA | 25 Sept 2025 | 2.07 | 2.06 |
| 11 Nov 2025 | Quarterly Result Announcement | NA | 11 Nov 2025 | 1.96 | 1.97 |
| 12 Feb 2026 | Quarterly Result Announcement | NA | 12 Feb 2026 | 2.05 | 2.10 |
| 07 May 2026 | Quarterly Result Announcement | NA | 07 May 2026 | 2.05 | 2.00 |
| 07 Aug 2026 | Quarterly Result Announcement | NA | 07 Aug 2026 | 1.81 | 1.89 |
Announcements
Announcement Under Regulation 30 (LODR)-Newspaper Publication4 days ago
4 days agoReg. 34 (1) Annual Report.5 days ago
5 days agoNotice Of The 44Th Annual General Meeting (AGM) And Annual Report Of The Company For The Financial Year 2025-265 days ago
5 days agoBoard Meeting Outcome for Outcome Of Board Meeting Held On 17.08.20267 days ago
7 days agoBoard Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1)(A) And Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 12, 2026
Aug 12, 2026Non Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI LODR Regulations 2015Aug 08, 2026
Aug 08, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 08, 2026
Aug 08, 2026Outcome Of Board Of Directors Meeting Of Vivanza Biosciences Limited (The Company)Aug 07, 2026
Aug 07, 2026Outcome Of Board Of Directors Meeting Of Vivanza Biosciences Limited (The Company)Aug 07, 2026
Aug 07, 2026Board Meeting Outcome for Outcome Of Board Meeting To Consider And Approve Unaudited Financial Results (Standalone And Consolidated) For Quarter Ended 30Th June 2026Aug 07, 2026
Aug 07, 2026Update on board meetingJul 31, 2026
Jul 31, 2026Board Meeting Intimation for The Consideration And Approval Of The Quarterly Financial Result Ended On 30Th June 2026.Jul 28, 2026
Jul 28, 2026Declaration Pursuant To Regulation 33(3)(D) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Jul 14, 2026
Jul 14, 2026Appointment of Company Secretary and Compliance OfficerJul 09, 2026
Jul 09, 2026Board Meeting Outcome for Outcome Of The Board Meeting Held On 09Th July 2026.Jul 09, 2026
Jul 09, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 07, 2026
Jul 07, 2026Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsJun 29, 2026
Jun 29, 2026Closure of Trading WindowJun 26, 2026
Jun 26, 2026Announcement under Regulation 30 (LODR)-Change in ManagementJun 18, 2026
Jun 18, 2026Board Meeting Outcome for Outcome Of Board Meeting To Be Held At 18Th June 2026Jun 18, 2026
Jun 18, 2026Board Meeting Intimation for Intimation Of The Meeting Of The Board Of Directors Pursuant To Regulations 29 And 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Jun 15, 2026
Jun 15, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 09, 2026
May 09, 2026Non Applicability Of Related Party Transaction Under Regulation 23(9) Of SEBI (LODR) Regulations 2015 For The Quarter And Year Ended 31St March 2026May 07, 2026
May 07, 2026Results- Quarterly And Year To End Dated 31St March 2026May 07, 2026
May 07, 2026Board Meeting Outcome for Audited Financial Results For The Quarter And Year Ended On 31St March 2026May 07, 2026
May 07, 2026Board Meeting Intimation for Rescheduling Of Board Meeting-Intimation Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.May 04, 2026
May 04, 2026Announcement under Regulation 30 (LODR)-Change in ManagementApr 30, 2026
Apr 30, 2026Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerApr 30, 2026
Apr 30, 2026Board Meeting Intimation for Board Meeting Intimation For Intimation Under Regulation 29(1)(A) And Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 28, 2026
Apr 28, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceApr 15, 2026
Apr 15, 2026Non-Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Apr 14, 2026
Apr 14, 2026Disclosures Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares & Takeovers) Regulations 2011Apr 09, 2026
Apr 09, 2026Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 09, 2026
Apr 09, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2026
Apr 07, 2026Closure of Trading WindowMar 23, 2026
Mar 23, 2026Announcement under Regulation 30 (LODR)-Change in DirectorateMar 17, 2026
Mar 17, 2026Announcement under Regulation 30 (LODR)-Resignation of DirectorMar 17, 2026
Mar 17, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 13, 2026
Feb 13, 2026Non-Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Feb 12, 2026
Feb 12, 2026Outcome Of The Board Meeting And Submission Of Un-Audited Financial Results For The Quarter And Nine Months Ended 31ST December 2025Feb 12, 2026
Feb 12, 2026Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of Un-Audited Financial Results For The Quarter And Nine Months Ended 31ST December 2025Feb 12, 2026
Feb 12, 2026Board Meeting Intimation for Consideration Of Financial Result For The Quarter And Nine Months Ended 31St December 2025Feb 05, 2026
Feb 05, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 02, 2026
Jan 02, 2026Closure of Trading WindowDec 26, 2025
Dec 26, 2025Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationDec 18, 2025
Dec 18, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportDec 17, 2025
Dec 17, 2025Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotDec 17, 2025
Dec 17, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 12, 2025
Dec 12, 2025Reg. 34 (1) Annual Report.Dec 04, 2025
Dec 04, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 15, 2025
Nov 15, 2025Technical Indicators
RSI(14)
Neutral 41.05
ATR(14)
Less Volatile 0.09
STOCH(9,6)
Neutral 49.02
STOCH RSI(14)
Oversold 0.00
MACD(12,26)
Bearish -0.02
ADX(14)
Weak Trend 15.90
UO(9)
Bearish 45.82
ROC(12)
Downtrend And Accelerating -7.89
WillR(14)
Neutral -70.59
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
